Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Optical detection of magnetic resonance (ODMR) has been employed to examine the homogeneity of the tryptophan environment, both of the isolated residue in solvent, and of tryptophan in glucagon and
lysozyme
and azurin B (Pseudomonas aeruginosa). From the shifts in the zero-field splittings, we can safely conclude that tryptophan in
lysozyme
, azurin B, or glucagon does not have the same type of solvent interaction as the free residue. However, by "burning holes" in the
OSMR
lines, it is evident that the lines in these cases are inhomogeneously broadened. From the relative line widths and hole widths, it appears that ODMR can be used to examine the relative diversity of interactions for a luminescent amino acid in a protein. We have followed the ODMR line characteristics in a progression from free N-acetyl-L-tryptophanamide, to tryptophan in
lysozyme
, to "denatured"
lysozyme
, and present evidence that the line widths narrow as the tryptophan residues become less solvent accessible.
...
PMID:Triplet state of tryptophan in proteins: the nature of the optically detected magnetic resonance lines. 62 48